For: | Spampatti M, Vlotides G, Spöttl G, Maurer J, Göke B, Auernhammer CJ. Aspirin inhibits cell viability and mTOR downstream signaling in gastroenteropancreatic and bronchopulmonary neuroendocrine tumor cells. World J Gastroenterol 2014; 20(29): 10038-10049 [PMID: 25110431 DOI: 10.3748/wjg.v20.i29.10038] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i29/10038.htm |
Number | Citing Articles |
1 |
Federica Cavalcoli, Sara Pusceddu, Alessandra Zilli, Gianluca Tamagno, Daniela Femia, Natalie Prinzi, John Travers, Dario Consonni, Clorinda Ciafardini, Dario Conte, Sara Massironi. Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm. Scandinavian Journal of Gastroenterology 2019; 54(9): 1111 doi: 10.1080/00365521.2019.1656773
|
2 |
Poulami Khan, Apoorva Bhattacharya, Debomita Sengupta, Shruti Banerjee, Arghya Adhikary, Tanya Das. Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53134-0
|
3 |
Xi-Feng Jin, Gerald Spöttl, Julian Maurer, Svenja Nölting, Christoph Josef Auernhammer. Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects. Cancers 2020; 12(2): 345 doi: 10.3390/cancers12020345
|
4 |
E T Aristizabal Prada, C J Auernhammer. Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets. Endocrine Connections 2018; 7(1): R1 doi: 10.1530/EC-17-0286
|
5 |
Svenja Nölting, Julian Maurer, Gerald Spöttl, Elke Tatjana Aristizabal Prada, Clemens Reuther, Karen Young, Márta Korbonits, Burkhard Göke, Ashley Grossman, Christoph J. Auernhammer, Olorunseun Ogunwobi. Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways. PLOS ONE 2015; 10(12): e0143830 doi: 10.1371/journal.pone.0143830
|
6 |
Gerassimos Lascaratos, Kai-Yin Chau, Haogang Zhu, Despoina Gkotsi, Deborah Kamal, Ivan Gout, Philip J. Luthert, Anthony H.V. Schapira, David F. Garway-Heath. Systemic PTEN-Akt1-mTOR pathway activity in patients with normal tension glaucoma and ocular hypertension: A case series. Mitochondrion 2017; 36: 96 doi: 10.1016/j.mito.2017.05.003
|
7 |
Elke Tatjana Aristizabal Prada, Michael Orth, Svenja Nölting, Gerald Spöttl, Julian Maurer, Christoph Auernhammer, Olorunseun Ogunwobi. The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells. PLOS ONE 2017; 12(5): e0178375 doi: 10.1371/journal.pone.0178375
|
8 |
Elke Tatjana Aristizabal Prada, Vera Heinzle, Thomas Knösel, Svenja Nölting, Gerald Spöttl, Julian Maurer, Christine Spitzweg, Martin Angele, Nina Schmidt, Felix Beuschlein, Günter K Stalla, Rainer Blaser, Klaus A Kuhn, Christoph J Auernhammer. Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors. Endocrine-Related Cancer 2018; 25(5): 547 doi: 10.1530/ERC-17-0201
|